On Friday, Icecure Medical Ltd (NASDAQ: ICCM) opened lower -5.88% from the last session, before settling in for the closing price of $1.19. Price fluctuations for ICCM have ranged from $0.47 to $1.63 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 2.44% over the past five years. Company’s average yearly earnings per share was noted 26.39% at the time writing. With a float of $40.31 million, this company’s outstanding shares have now reached $58.70 million.
Icecure Medical Ltd (ICCM) Insider Updates
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Icecure Medical Ltd is 41.31%, while institutional ownership is 0.37%.
Icecure Medical Ltd (ICCM) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.08 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.08) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.39% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.41% during the next five years compared to 2.44% growth over the previous five years of trading.
Icecure Medical Ltd (NASDAQ: ICCM) Trading Performance Indicators
Check out the current performance indicators for Icecure Medical Ltd (ICCM). In the past quarter, the stock posted a quick ratio of 0.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 27.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.18 in one year’s time.
Technical Analysis of Icecure Medical Ltd (ICCM)
Icecure Medical Ltd (NASDAQ: ICCM) saw its 5-day average volume 5.35 million, a positive change from its year-to-date volume of 0.77 million. As of the previous 9 days, the stock’s Stochastic %D was 68.64%.
During the past 100 days, Icecure Medical Ltd’s (ICCM) raw stochastic average was set at 65.63%, which indicates a significant decrease from 68.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0776 in the past 14 days, which was higher than the 0.0696 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9764, while its 200-day Moving Average is $1.0836. Nevertheless, the first resistance level for the watch stands at $1.1767 in the near term. At $1.2333, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.2867. If the price goes on to break the first support level at $1.0667, it is likely to go to the next support level at $1.0133. Assuming the price breaks the second support level, the third support level stands at $0.9567.
Icecure Medical Ltd (NASDAQ: ICCM) Key Stats
There are currently 58,697K shares outstanding in the company with a market cap of 76.94 million. Presently, the company’s annual sales total 3,290 K according to its annual income of -15,320 K. Last quarter, the company’s sales amounted to 530 K and its income totaled 3,360 K.
